Gustave Roussy immune score predicts survival outcome of patients with metastatic urothelial carcinoma treated with pembrolizumab: A multicenter study of 321 patients (YUSHIMA study)

被引：0
|
作者：
Tanabe, K. [1 ]
Shuichiro, K. [1 ]
Katsushi, N. [2 ]
Junji, Y. [3 ]
Yukihiro, O. [4 ]
Tetsuo, O. [5 ]
Ryoji, T. [6 ]
Akira, N. [1 ]
Masataka, Y. [7 ]
Tetsuro, T. [8 ]
Kazutaka, S. [9 ]
Yasuyuki, S. [10 ]
Fumitaka, K. [11 ]
Yukio, K. [12 ]
Hajime, T. [13 ]
Soichiro, Y. [13 ]
Yasuhisa, F. [13 ]
机构：
[1] Saitama Red Cross Hosp, Dept Urol, Saitama, Japan
[2] Kohnodai Hosp, Dept Urol, Chiba, Japan
[3] Canc Inst Hosp, Dept Urol, Tokyo, Japan
[4] Japanese Red Cross Omori Hosp, Dept Urol, Tokyo, Japan
[5] JA Toride Med Ctr, Dept Urol, Ibaraki, Japan
[6] Tokyo Metropolitan Otsuka Hosp, Dept Urol, Tokyo, Japan
[7] Tokyo Metropolitan Tama Nambu Chiiki Hosp, Dept Urol, Tokyo, Japan
[8] Showa Gen Hosp, Dept Urol, Tokyo, Japan
[9] Dokkyo Med Univ Saitama Med Ctr, Dept Urol, Saitama, Japan
[10] Tsuchiura Kyodo Gen Hosp, Dept Urol, Ibaraki, Japan
[11] Komagome Hosp, Dept Urol, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[12] Saitama Prefectural Canc Ctr, Dept Urol, Saitama, Japan
[13] Tokyo Med & Dent Univ, Dept Urol, Tokyo, Japan
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0752
引用
收藏
页码：S1729 / S1730
页数：2
相关论文
共 50 条
  • [21] Is the occurrence of higher adverse effects associated with better oncological outcome in metastatic urothelial carcinoma patients treated with pembrolizumab?
    Hayakawa, Nozomi
    Kikuchi, Eiji
    Ogihara, Koichirou
    Hattori, Seiya
    Yoshimine, Shunsuke
    Shirotake, Suguru
    Okabe, Takashi
    Yamashita, Ryo
    Oya, Mototsugu
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [22] The Gustave Roussy Immune score (GRIm score) as a novel prognostic score for early breast cancer patients: A real-world retrospective study
    Tan, Chunlei
    Xu, Jinling
    Yang, Xiaotian
    Wu, Danping
    Zhang, Shiyuan
    Liu, Shuqiang
    Yu, Boqian
    Huang, Yuanxi
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (14): : 2640 - 2654
  • [23] Prognostic impact of radiological tumor burden in patients with metastatic urothelial carcinoma treated with pembrolizumab
    Katayama, Satoshi
    Iwata, Takehiro
    Kawada, Tasushi
    Okamoto, Yusuke
    Sano, Yuho
    Kawago, Yuya
    Miyake, Shuji
    Moriwake, Takatoshi
    Kuinose, Aya
    Horikawa, Yuhei
    Tsuboi, Kazuma
    Tsuboi, Ichiro
    Sakaeda, Kazuma
    Nakatsuka, Hirokazu
    Takamoto, Atsushi
    Hirata, Takeshi
    Shirasaki, Yoshinori
    Yamasaki, Taku
    Morinaka, Hirofumi
    Nagasaki, Naoya
    Hara, Takafumi
    Ochi, Akinori
    Okumura, Misa
    Watanabe, Tomofumi
    Sekito, Takanori
    Kawano, Kaoru
    Horii, Satoshi
    Yamanoi, Tomoaki
    Nagao, Kentaro
    Yoshinaga, Kasumi
    Maruyama, Yuki
    Tominaga, Yusuke
    Sadahira, Takuya
    Nishimura, Shingo
    Edamura, Kohei
    Kobayashi, Tomoko
    Kusumi, Norihiro
    Kurose, Kyohei
    Yamamoto, Yasuo
    Sugimoto, Morito
    Nakada, Tetsuya
    Sasaki, Katsumi
    Takenaka, Tadasu
    Ebara, Shin
    Miyaji, Yoshiyuki
    Wada, Koichiro
    Kobayashi, Yasuyuki
    Araki, Motoo
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (03) : 70.e11 - 70.e18
  • [24] Impact of angiotensin system inhibitors (ASI) on outcome in sunitinib (SU)- treated patients for metastatic renal cell carcinoma (mRCC): Gustave Roussy experience
    Derosa, Lisa
    Izzedine, Hassane
    Le Teuff, Gwenael
    Albiges, Laurence
    Escudier, Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [25] Glasgow prognostic score predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib: a multicenter analysis
    Tada, Toshifumi
    Kumada, Takashi
    Hiraoka, Atsushi
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    Ochi, Hironori
    Yasuda, Satoshi
    Toyoda, Hidenori
    Hatanaka, Takeshi
    Kakizaki, Satoru
    Shimada, Noritomo
    Kawata, Kazuhito
    Tanaka, Takaaki
    Ohama, Hideko
    Nouso, Kazuhiro
    Morishita, Asahiro
    Tsutsui, Akemi
    Nagano, Takuya
    Itokawa, Norio
    Okubo, Tomomi
    Arai, Taeang
    Imai, Michitaka
    Naganuma, Atsushi
    Aoki, Tomoko
    Koizumi, Yohei
    Nakamura, Shinichiro
    Joko, Kouji
    Hiasa, Yoichi
    Kudo, Masatoshi
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (08) : 857 - 864
  • [26] Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab
    Yamamoto, Shumpei
    Fukushima, Hiroshi
    Fukuda, Shohei
    Uehara, Sho
    Yasuda, Yosuke
    Tanaka, Hajime
    Yoshida, Soichiro
    Yokoyama, Minato
    Matsuoka, Yoh
    Fujii, Yasuhisa
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (04) : 410 - 418
  • [27] The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab
    Lenci, Edoardo
    Cantini, Luca
    Pecci, Federica
    Cognigni, Valeria
    Agostinelli, Veronica
    Mentrasti, Giulia
    Lupi, Alessio
    Ranallo, Nicoletta
    Paoloni, Francesco
    Rinaldi, Silvia
    Nicolardi, Linda
    Caglio, Andrea
    Aerts, Sophie
    Cortellini, Alessio
    Ficorella, Corrado
    Chiari, Rita
    Di Maio, Massimo
    Dingemans, Anne-Marie C.
    Aerts, Joachim G. J. V.
    Berardi, Rossana
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (05) : 1 - 14
  • [28] Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Comprehensive Treatment Outcomes and Prognostic Insights From a Multicenter Real-World Study (YUSHIMA Study)
    Nakamura, Yuki
    Tanaka, Hajime
    Numao, Noboru
    Inoue, Masaharu
    Yoshinaga, Atsushi
    Kawamura, Naoko
    Tanabe, Kenji
    Izumi, Keita
    Yamamoto, Takanobu
    Uehara, Sho
    Maezawa, Yuya
    Soma, Takahiko
    Toide, Masahiro
    Takazawa, Ryoji
    Araki, Saori
    Yoshida, Soichiro
    Fujii, Yasuhisa
    CLINICAL GENITOURINARY CANCER, 2025, 23 (02)
  • [29] Patient-reported outcomes for patients with locally advanced or metastatic urothelial carcinoma under pembrolizumab: A prospective multicenter observational study.
    Annakib, Soufyan
    Bekoy, Yona Dibert
    Chevallier, Thierry
    Fiteni, Frederic
    Houede, Nadine
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [30] ANTIBIOTIC USE AND SURVIVAL OF PATIENTS RECEIVING PEMBROLIZUMAB FOR CHEMOTHERAPY-RESISTANT METASTATIC UROTHELIAL CARCINOMA
    Ishiyama, Yudai
    Kondo, Tsunenori
    Nemoto, Yuki
    Kobari, Yuki
    Ishihara, Hiroki
    Tachibana, Hidekazu
    Yoshida, Kazuhiko
    Hashimoto, Yasunobu
    Takagi, Toshio
    Iizuka, Junpei
    Tanabe, Kazunari
    JOURNAL OF UROLOGY, 2021, 206 : E248 - E248
12345